 Phoenix, Arizona--Newsfile Corp. - May 7, 2021 - The Stock Day Podcast welcomed Lexaria Bioscience Corp. NASDAQ: LEXX the Company, a company with a proprietary drug delivery technology, DehydraTECHTM, which improves the way active pharmaceutical ingredients APIs enter the bloodstream. CEO of the Company, Chris Bunka, joined Stock Day host Everett Jolly.Jolly began the interview by commenting on a recent press release detailing the Companys involvement in the hypertension market. What are your thoughts about... 